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TheVAOﬂavoprotein family is a rapidly growing family of oxidoreductases that favor the covalent binding of the FAD cofactor. In this
review we report on the catalytic properties of some newly discovered VAO family members and their mode of ﬂavin binding. Covalent
binding of the ﬂavin is a self-catalytic post-translational modiﬁcation primarily taking place in oxidases. Covalent ﬂavinylation increases
the redox potential of the cofactor and thus its oxidation power. Recent ﬁndings have revealed that some members of the VAO family
anchor the ﬂavin via a dual covalent linkage (6-S-cysteinyl-8a-N1-histidyl FAD). Some VAO-type aldonolactone oxidoreductases favor
the non-covalent binding of the ﬂavin cofactor. These enzymes act as dehydrogenases, using cytochrome c as electron acceptor.
 2008 Elsevier Inc. All rights reserved.
Keywords: Alditol oxidase; Chitooligosaccharide oxidase; Covalent ﬂavinylation; Eugenol oxidase; Flavoenzyme; L-Galactono-1,4-lactone dehydroge-
nase; Vanillyl-alcohol oxidase; VAO family; Vitamin CThe vanillyl-alcohol oxidase (VAO)1 ﬂavoprotein family
comprises a group of enzymes that share a conserved FAD-
binding domain [1]. VAO family members are involved in a
wide variety of metabolic processes in all kingdoms of life.
A remarkable feature of the FAD-binding module of this
protein family is that it favors the covalent attachment of
the ﬂavin cofactor. The ﬁrst VAO family members identi-
ﬁed with such a covalent link concerned 6-hydroxy-D-nico-
tine oxidase (HDNO), involved in nicotine catabolism in
Arthrobacter nicotinovorans [2,3] and p-cresol methylhy-0003-9861/$ - see front matter  2008 Elsevier Inc. All rights reserved.
doi:10.1016/j.abb.2008.01.027
* Corresponding author. Fax: +31 317 484801.
E-mail address: willem.vanberkel@wur.nl (W.J.H. van Berkel).
1 Abbreviations used: AldO, alditol oxidase; ADPS, alkyldihydroxy
acetonephosphate synthase; AknOx, aclacinomycin oxidoreductase; BBE,
S-reticuline oxidase (berberine bridge enzyme); ChitO, chitooligosaccha-
ride oxidase; EUGO, eugenol oxidase; FAD, ﬂavin adenine dinucleotide;
FMN, ﬂavin mononucleotide; GALDH, L-galactono-1,4-lactone
dehydrogenase; HDNO, 6-hydroxy-D-nicotine oxidase; MurB, N-acety-
lenolpyruvyl glucosamine reductase; PCMH, p-cresol methylhydroxylase;
TbALO, Trypanosoma brucei arabinonolactone oxidase; TcGAL, Try-
panosoma cruzi galactonolactone oxidase; VAO, vanillyl alcohol oxidase.droxylase (PCMH), involved in the microbial detoxiﬁca-
tion of phenols [4]. Only recently, it was found that the
isoalloxazine ring of the ﬂavin cofactor can be tethered to
the apoprotein via a dual covalent linkage [5]. All bi-cova-
lent ﬂavoenzymes characterized thus far share a VAO fold.
Covalent ﬂavoenzymes are less widespread than their
counterparts containing a dissociable ﬂavin cofactor [6].
Several distinct types of covalent ﬂavin binding have been
recognized [6,7], but tethering of the 8a-methyl group of
the ﬂavin isoalloxazine ring to a histidine residue is most
frequently observed. Enzymatic degradation to the level
of the aminoacyl riboﬂavin moiety has been the conven-
tional method to characterize the covalent protein–ﬂavin
link [8,9]. A more sophisticated approach involves the
structural characterization of the isolated ﬂavinylated pep-
tide without submitting it to subsequent enzymatic degra-
dation [10]. Alternatively, the mode of covalent
ﬂavinylation can be determined from the three-dimensional
protein structure or predicted in silico [1]. The importance
of the covalent link can be analyzed through the functional
characterization of site-directed mutant proteins [11–14].
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ﬂavinylation is a self-catalytic process, dependent on the
primary folding of the polypeptide chain [7,15]. The ability
of covalent incorporation of FAD by the apoprotein was
ﬁrst demonstrated for HDNO [16]. The formation of the
ﬂavin–protein linkage was promoted by the addition of
small organic compounds, e.g. glycerol and glycerol-3-
phosphate. For VAO it was shown that covalent ﬂavinyla-
tion is not needed for eﬀective binding of the cofactor [13].
This suggests that formation of the histidyl–FAD bond is
preceded by non-covalent binding of the cofactor to the
folded apoprotein (lock-and-key). It was also discovered
that covalent binding of FAD to His422 in VAO requires
the presence of an activating nucleophile, His61, in the
FAD domain [17]. His422 replacements, prohibiting for-
mation of the histidyl–FAD linkage, showed that covalent
ﬂavinylation increases the redox potential of VAO and thus
its oxidation power [13]. For PCMH it was shown that
binding of the cytochrome subunit is necessary for the gen-
eration of the 8a-O-tyrosyl FAD bond [18], and that the
intermolecular subunit interactions induce small structural
changes in the ﬂavin-binding pocket that optimize the
redox properties of the covalently bound FAD [19].
In this review, we report on the catalytic properties of
some newly discovered VAO family members and their
mode of ﬂavin binding. Some new information about the
aldonolactone oxidoreductase subfamily is presented as
well.
New members of the VAO ﬂavoprotein family
With the aid of the 3D-structure and sequence of VAO
from Penicillium simplicissimum [20], about 50 diﬀerent
VAO homologs originally were identiﬁed [1]. Among these
were several characterized ﬂavoenzymes like 6-hydroxy-D-
nicotine oxidase, S-reticuline oxidase, p-cresol methylhy-
droxylase, D-arabinono-1,4-lactone oxidase, D-lactate
dehydrogenase, cholesterol oxidase, L-gulono-1,4-lactone
oxidase, L-galactono-1,4-lactone dehydrogenase, hexose
oxidase and alkyldihydroxyacetonephosphate synthase
(ADPS) (Table 1). UDP-N-acetylenolpyruvyl glucosamine
reductase (MurB), involved in the biosynthesis of the bac-
terial cell wall, was also identiﬁed as a family member,
despite a low sequence similarity. During the last decade
several new VAO family members have emerged. These
include among others alditol oxidase, chitooligosaccharide
oxidase, glucooligosaccharide oxidase, lactose oxidase,
eugenol dehydrogenase, eugenol oxidase, cytokinin dehy-
drogenase, aclacinomycin oxidoreductase and Dbv29, a
glycopeptide hexose oxidase. The mode of ﬂavin binding
of these enzymes is summarized in Table 1.
Histidyl-FAD enzymes
Analysis of VAO-type protein sequences has revealed
that the target residue for covalent ﬂavinylation is part
of a conserved sequence region [1]. The linking histidineis typically found in the N-terminal part of the protein
sequence downstream of three relatively small residues
(e.g. xGGGHx sequence). Examples of such His-FAD
containing proteins are HDNO [2,21], cholesterol oxidase
[22], cytokinin dehydrogenase [23,24] and alditol oxidase
[25]. The only exceptions to this rule are VAO and some
close homologs (PCMH [26], and eugenol oxidase [27]).
These enzymes contain a linking residue that is closer to
the C-terminus. This suggests that during evolution, at
least in two occasions the covalent ﬂavin–protein linkage
was formed at the two sequence regions (loops) that are
in close contact with the dimethylbenzyl moiety of the ﬂa-
vin isoalloxazine ring in the VAO fold (Fig. 1). The N-ter-
minal loop preferentially binds the ﬂavin via the N1 atom
of the histidine side chain (Table 1). In accordance with
this, HDNO contains 8a-N1-histidyl FAD [19], instead
of the originally identiﬁed 8a-N3-histidyl FAD [3].
Sequence alignments suggest that D-gluconolactone
oxidase might also contain 8a-N1-histidyl FAD (Table
1). Contrarily, VAO contains an 8a-N3-histidyl FAD
cofactor.
Recently discovered VAO members containing a histi-
dyl-FAD include cytokinin dehydrogenase, alditol oxidase
and eugenol oxidase. Cytokinin dehydrogenase (CKX) is
involved in the enzymatic degradation of cytokinins (N6-
substituted purine derivatives), which play a major role in
growth regulation in plants. The cytokinin dehydrogenase
reaction involves the oxidation of the secondary amine
group on the side-chain of the adenine ring resulting in
cleavage of the side chain (Fig. 2A). The enzyme was ini-
tially classiﬁed as an oxidase but oxygen is only a poor sub-
strate, a range of quinones have been identiﬁed as eﬃcient
electron acceptors [28]. Based on this, CKX has now been
classiﬁed as a dehydrogenase. The crystal structure of
maize CKX1 complexed with a cytokinin imine suggests
that the product prevents the reduced ﬂavin to react with
molecular oxygen [23,29]. Typically, plant genomes contain
a multitude of CKX genes.
Most VAO-type proteins containing a His-FAD cofac-
tor have been found to act as an oxidase. This correlation
has been used to discover novel covalent ﬂavoprotein oxi-
dases by genome database mining. An example of this
approach of enzyme discovery is the recent identiﬁcation
of alditol oxidase (AldO) from Streptomyces coelicolor
A3 [25]. AldO catalyzes the oxidation of the C1 hydroxyl
group of preferably alditols into the corresponding alde-
hydes (Fig. 2B).
AldO is closely related to xylitol oxidase and sorbitol
oxidase from other Streptomyces isolates [30,31] and all
three oxidases display overlapping substrate speciﬁcities.
AldO is most active with xylitol and sorbitol, which are
converted into D-xylose and D-glucose, respectively [25].
The enzyme is an intracellular monomeric protein with
a molecular mass of 45 kDa and could be expressed in
impressive quantities (350 mg per liter culture) using Esch-
erichia coli as expression host [25]. The recent elucidation
of the crystal structure of AldO conﬁrmed that the FAD
Table 1
(Predicted) FAD-binding mode of VAO family members
Enzyme EC number Flavin Ref.
Histidyl-FAD enzymes
Vanillyl-alcohol oxidase 1.1.3.38 8a-N3-histidyl FAD [20,69]
Eugenol oxidase 1.1.3.x 8a-N3-histidyl FADa [27]
6-Hydroxy-D-nicotine oxidase 1.5.3.6 8a-N1-histidyl FADb [21]
Cholesterol oxidase 1.1.3.6 8a-N1-histidyl FAD [22]
D-Arabinono-1,4-lactone oxidase 1.1.3.37 8a-N1-histidyl FAD [70]
L-Gulono-1,4-lactone oxidase 1.1.3.8 8a-N1-histidyl FAD [71]
D-Gluconolactone oxidase 1.1.3.x 8a-N3-histidyl FADc [72]
Alditol oxidase 1.1.3.x 8a-N1-histidyl FAD [32]
Cytokinin dehydrogenase 1.5.99.12 8a-N1-histidyl FAD [23,28]
Cysteinyl-histidyl FAD enzymes
Glucooligosaccharide oxidase 1.1.3.x 6-S-cysteinyl, 8a-N1-histidyl FAD [5]
Chitooligosaccharide oxidase 1.1.3.x 6-S-cysteinyl, 8a-N1-histidyl FADd [45]
Hexose oxidase 1.1.3.5 6-S-cysteinyl, 8a-N1-histidyl FAD [37]
S-Reticuline oxidase 1.21.3.3 6-S-cysteinyl, 8a-N1-histidyl FAD [38]
Aclacinomycin oxidoreductase 1.1.3.x 6-S-cysteinyl, 8a-N1-histidyl FAD [44]
Dbv29 (glycopeptide hexose oxidase) 1.1.3.x 6-S-cysteinyl, 8a-N1-histidyl FMN [43]
Other covalent linkages
p-Cresol methylhydroxylase 1.17.99.1 8a-O-tyrosyl FAD [26]
Eugenol hydroxylase 1.17.99.x 8a-O-tyrosyl FADe [35]
Non-covalent ﬂavoenzymes
Alkyldihydroxyacetonephosphate synthase 2.5.1.26 FAD [48]
D-Lactate dehydrogenase 1.1.1.28 FAD [49]
L-Galactono-1,4-lactone dehydrogenase 1.3.2.3 FAD [58]
UDP-N-acetylenolpyruvylglucosamine reductase 1.1.1.158 FAD [50]
a Prediction from homology modeling with VAO [27].
b Originally identiﬁed as 8a-N3-histidyl FAD [3].
c Prediction from amino acid sequence gives 8a-N1-histidyl FAD.
d Prediction from homology modeling with GOOX [45].
e Prediction from amino acid sequence gives 8a-O-tyrosyl FAD.
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(His46) via an 8a-N1-histidyl–FAD linkage [32]. The
H46A mutant was expressed as the apoprotein in E. coli
and found to be partially insoluble. This suggests that
the covalent ﬂavin–protein interaction is crucial for the
structural integrity of AldO [25]. Crystal structures of
AldO complexed with alditols have revealed the molecular
basis for the selective oxidation reactions catalyzed by
AldO. By an extensive hydrogen bond network, alditols
are positioned with respect to the ﬂavin cofactor in such
a way that only one terminal hydroxyl group is oxidized.
A detailed kinetic analysis has shown that AldO employs
a ternary complex kinetic mechanism for the oxidation of
xylitol (Km = 320 lM, kcat = 13 s
1). Xylitol rapidly
reduces the FAD cofactor (kred = 99 s
1) upon which a
binary complex is formed between reduced AldO and D-
xylose. While complexed with the oxidation product, the
ﬂavin cofactor is able to utilize molecular oxygen as elec-
tron acceptor (1.4  105 M1 s1). Besides xylitol and
related alditols, AldO also converts other aliphatic alco-
hols. AldO shows considerable sequence and structural
homology with cholesterol oxidase, but does not accept
bulky hydrophobic substrates. This can be explained by
the narrow-binding pocket near the ﬂavin cofactor which
determines the substrate speciﬁcity.Another VAO-type histidyl-FAD containing oxidase
that was recently discovered by utilizing genome sequence
information is eugenol oxidase [27]. By analyzing the avail-
able bacterial genome sequences it was found that the pro-
teome of the actinomycete Rhodococcus sp. RHA1 harbors
a protein that shows 45% sequence identity to fungal VAO.
The presence of a conserved histidine in its C-terminal
region suggested that also in this protein, the FAD is cova-
lently linked as in VAO. Indeed, heterologous expression in
E. coli resulted in overproduction of ﬂavinylated enzyme.
Part of the recombinant protein was puriﬁed as the apopro-
tein. Addition of FAD to the puriﬁed protein resulted in
fully ﬂavinylated protein. This again conﬁrms the autocat-
alytic mechanism of covalent FAD incorporation. Charac-
terization of the enzyme revealed that it is most active as
oxidase with eugenol (Km = 1.0 lM, kcat = 3.1 s
1) and
therefore it was named eugenol oxidase (EUGO) (Fig. 2C).
VAO and EUGO accept similar substrates, but with sig-
niﬁcantly diﬀerent catalytic eﬃciencies. For example, while
VAO is able to eﬀectively hydroxylate 4-alkylphenols and
to deaminate aromatic amines, EUGO is poorly active on
these substrates. Another striking diﬀerence between
VAO and EUGO is their oligomerization state: while
VAO forms stable octamers, EUGO is a dimeric enzyme.
Inspection of the VAO structure and sequence comparison
Fig. 1. Covalent ﬂavin–protein linkages in the VAO fold. (A) Crystal
structure of alditol oxidase with 8a-N1-histidyl FAD [32]. (B) 3D model of
eugenol oxidase with 8a-N3-histidyl FAD [27]. (C) 3D model of
chitooligosaccharide oxidase with 6-S-cysteinyl-8a-N1-histidyl FAD [45].
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creates dimer–dimer interactions and thereby stabilizesoctamers. This loop region is absent in the EUGO
sequence. A nice feature, when compared with VAO, is
the fact that EUGO is expressed in large quantities in
E. coli facilitating production of this novel oxidase.
The substrate speciﬁcities of VAO and EUGO have
some resemblance to that of the ﬂavocytochromes PCMH
[33] and eugenol dehydrogenase [34]. The latter enzyme is
also referred to as eugenol hydroxylase [35]. Based on
sequence comparisons [18,35,36] eugenol hydroxylase is
predicted to contain 8a-O-tyrosyl FAD.Histidyl–cysteinyl FAD enzymes
Only very recently it was discovered that in some ﬂavo-
proteins the ﬂavin cofactor is covalently attached to two
amino acid residues. This bi-covalent linkage of FAD
was ﬁrst revealed in 2005 by elucidating the crystal struc-
ture of glucooligosaccharide oxidase [5]. Glucooligosaccha-
ride oxidase preferably oxidizes cellooligosaccharides, that
can reach the active site via an open carbohydrate-binding
groove. In this fungal carbohydrate oxidase the FAD is
tethered to Cys130 and His70 via, respectively, the 6- and
8a-position of the isoalloxazine ring (Fig. 3).
Based on this ﬁnding, it was recognized that also other
established covalent ﬂavoproteins may contain a bi-cova-
lent FAD as cofactor. A dual covalent linkage was con-
ﬁrmed for hexose oxidase and S-reticuline oxidase
(berberine bridge enzyme, BBE) [37,38] and probably is
also the case for tetrahydrocannabinolic acid synthase, an
enzyme involved in controlling marijuana psychoactivity
[39]. A bi-covalent FAD cofactor is also predicted for
two carbohydrate oxidases from sunﬂower and tobacco
[40,41], and for the lactose oxidase from Microdochium
nivale [42]. Apart from these known covalent ﬂavoproteins,
several new bi-covalent ﬂavoproteins have been described
recently: Dbv29, a glycopeptide hexose oxidase [43], acla-
cinomycin oxidoreductase (AknOx) [44] and chitooligosac-
charide oxidase [45] (Table 1). All above-mentioned bi-
covalent ﬂavoproteins represent VAO-type enzymes, again
showing that the VAO-fold is favorable for covalent pro-
tein–ﬂavin interactions.
The reactions catalyzed by some bi-covalent ﬂavopro-
teins demonstrate the unusual catalytic power of these
enzymes. BBE for example, catalyzes the oxidative cycliza-
tion of the N-methyl group of S-reticuline in the benzophe-
nanthridine alkaloid biosynthesis in plants [46]. This
reaction involves two steps, the oxidation of the methylene
iminium ion and the stereospeciﬁc ring closure forming the
berberine bridge of S-scoulerine (Fig. 4A). Another unu-
sual bi-covalent ﬂavoprotein is AknOx, which catalyzes
the last two steps in the biosynthesis of the polyketide anti-
biotic aclacinomycin in Streptomyces species. AknOx uses
the same active site to catalyze these two consecutive
FAD-dependent reactions but uses two distinct sets of cat-
alytic residues to accomplish this. The ﬁrst reaction
involves the oxidation of the terminal sugar residue rhodi-
Fig. 2. Reactions catalyzed by the histidyl-FAD enzymes CKX (A), AldO (B) and EUGO (C).
Fig. 3. Bi-covalent FAD linkage in glucooligosaccharide oxidase: 6-S-
cysteinyl, 8a-N1-histidyl FAD [5].
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converted to L-aculose by a desaturation step (Fig. 4B) [44].
The glycopeptide hexose oxidase Dbv29 is the ﬁrst
reported FMN-containing bi-covalent ﬂavoprotein.
Dbv29 catalyzes the four-electron oxidation of the N-acyl-
glucosaminyl substituent to N-acylaminoglucuronic acid
during the maturation of the glycopeptide A40926 antibi-
otic (Fig. 4C) [43].
As part of another genome database mining eﬀort a
chitooligosaccharide oxidase (ChitO) from Fusarium
graminearum was discovered and investigated [45]. In
contrast to glucooligosaccharide oxidase, ChitO is highly
active with N-acetylated mono- and oligosaccharides
(Fig. 4D). Chitotetraose was found to be the best sub-
strate (Km = 250 lM, kcat = 6.3 s
1). ChitO also converts
non-modiﬁed saccharides, e.g. glucose, cellobiose and lac-
tose, but with a much lower catalytic eﬃciency. Based on
the sequence similarity with glucooligosaccharide oxidase,
a structural model of ChitO was constructed. This
enabled the identiﬁcation of residues that form the chi-tooligosaccharide-binding pocket. Based on this model,
a speciﬁc glutamine residue was replaced by an arginine.
As predicted, the engineered protein showed a somewhat
lower aﬃnity for N-acetylated substrates while the cata-
lytic eﬃciency for non-acetylated carbohydrates
improved 20-fold [45]. This conﬁrms that the respective
residue is crucial for the recognition of speciﬁc classes of
oligosaccharides. The availability of recombinant ChitO
provides new opportunities to perform selective modiﬁca-
tions of (oligo)saccharides.
So far, little is known about the biological signiﬁcance
of bi-covalent ﬂavinylation. Single mutants of Dbv29
(H91A or C151A) showed comparable activity to wild
type, while the double mutant retained only 10% activity
[43]. From this it was argued that the bi-covalent linkage
is required for a proper orientation of the ﬂavin in the
active site. The bi-covalent link in S-reticuline oxidase
was also studied by mutagenic analysis [47]. The
C166A variant showed an impaired ﬂavin reduction rate
of 370-fold and a decrease in redox potential, +53 mV
vs. +132 mV for the wild-type enzyme. His104 protein
variants could not be expressed in suﬃcient amounts
for biochemical studies. From these data it was con-
cluded that 6-S-cysteinylation of the ﬂavin tunes the
redox potential. In fact, the redox potential of wild-type
S-reticuline oxidase is exceptionally high which is in line
with the proposed rationale of covalent ﬂavinylation, i.e.
increasing the oxidative power of the respective
enzyme.
Genomic data indicate that many new bi-covalent ﬂa-
voenzymes still need to be discovered. Several of these
hypothetical enzymes are found, for instance, in Strepto-
myces species [44] and in plants.
Fig. 4. Reactions catalyzed by the bi-covalent ﬂavoproteins BBE (A), AknOx (B), Dbv29 (C) and ChitO (D).
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Within the VAO family alsomembers exist that bind their
ﬂavin cofactor non-covalently (Table 1). Generally the His
residue in the conserved sequence region of theFAD-binding
domain is lacking in these enzymes, and they do not react
with molecular oxygen. For ADPS, D-lactate dehydroge-
nase, and MurB the crystal structures have been solved
[48–50]. ADPS catalyzes ether bond formation in phospho-
lipids, the constituents of eukaryotic cell membranes
(Fig. 5A). The ﬂavin cofactor is presumed to be involved in
this non-redox reaction by trapping the dihydroxyacetone-
phosphate intermediate via covalent binding [48].
The peripheral membrane protein D-lactate dehydroge-
nase from E. coli catalyzes the oxidation of D-lactate to
pyruvate, using quinone as electron acceptor. Besides theFAD-binding domain and the cap-domain, the enzyme
also harbors a membrane-binding domain which interacts
with the negatively charged phospholipid head groups of
the membrane [49].
MurB is involved in peptidoglycan biosynthesis in bacte-
ria, it catalyzes the reduction of enolpyruvyl-UDP-N-
acetylglucosamine to UDP-N-acetylmuramic acid using
NADPH as electron donor (Fig. 5B). The MurB structure
consists of three domains, the typical VAO-type FAD-
binding domain, and two additional domains comprising
the substrate-binding site [50].
L-Galactono-1,4-lactone dehydrogenase (GALDH) is
another VAO family member that binds the FAD in a
non-covalent mode. This aldonolactone oxidoreductase is
responsible for completing the biosynthesis of vitamin C
in plants (Fig. 5C).
Fig. 5. Reactions catalyzed by the non-covalent VAO members ADPS (A), MurB (B) and GALDH (C).
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ﬂower mitochondria by Mapson and Breslow in the 1950s
[51]. Since then the enzyme was isolated from the mito-
chondria from a number of plants [52–55]. More recently,
recombinant forms have become available for cauliﬂower,
tobacco and Arabidopsis thaliana GALDH [58,56,57].
GALDH homologs in animals (L-gulono-1,4-lactone oxi-
dase), yeast (D-arabinono-1,4-lactone oxidase) and fungi
(D-gluconolactone oxidase), are involved in the synthesis
of L-ascorbate or its analogs D-erythorbate and D-erythro-
ascorbate [59–61]. In contrast to GALDH, these oxidases
contain a covalently bound FAD (Table 1). Recently also
a bacterial gulonolactone dehydrogenase [62] and two
aldonolactone oxidases from trypanosome parasites
[63,64] have been identiﬁed.
The aldonolactone oxidoreductases form a separate
clade in the VAO family (Fig. 6). The plant GALDH
enzymes share about 80–90% sequence identity but they
have less than 25% of sequence identity with other aldono-
lactone oxidoreductases. The highest degree of sequence
identity within this sub-family is found in the FAD-binding
domain. No crystal structure is available for GALDH or
its homologs and little is known about the nature of the
active site and the catalytic mechanism. A recurrent feature
within the group of aldonolactone oxidoreductases is the
sensitivity towards thiol reactive compounds, suggesting
the involvement of cysteine residues in catalysis
[51,53,64–66].
GALDH is presumably localized in the mitochondrial
intermembrane space associated with mitochondrial com-plex I [67] where it shuttles electrons into the electron trans-
port chain via cytochrome c [68]. Mature GALDH from A.
thaliana (AtGALDH) can be eﬃciently produced in E. coli
when omitting the N-terminal mitochondrial targeting
sequence [58]. The monomeric protein shows a high enan-
tio-preference for L-galactono-1,4-lactone (Km = 0.17 mM,
kcat = 134 s
1), though the L-gulono-1,4-lactone isomer is
also oxidized at signiﬁcant rate (Km = 13.1 mM,
kcat = 4 s
1). Thus, a diﬀerence in orientation of the 3-
hydroxyl group of the substrate is responsible for a 100-
fold higher Km and 2500-fold lower catalytic eﬃciency.
Most aldonolactone oxidoreductases use molecular oxy-
gen as electron acceptor and contain a covalently bound
histidyl-FAD (Table 1) [21,22,25]. Plant GALDH lacks
this His-residue but contains a Leu instead. Replacement
of Leu56 in AtGALDH by His did not result in covalent
incorporation of FAD. Instead, FAD was more weakly
bound in the mutant than in the wild-type protein [58].
Replacing Leu56 with Ala or Cys also yielded variants with
loosely bound FAD. Variants L56I and L56F were similar
to wild-type AtGALDH, and contained tightly bound
FAD. The apo forms of the Leu56 variants could easily
be reconstituted by the addition of FAD and their ﬂavin
absorption properties were nearly identical to that of the
wild-type enzyme. The kinetic parameters of the Leu56
variants were determined and a rough correlation was
found between the bulkiness of the residue at position 56
and the Michaelis-constant for L-galactono-1,4-lactone.
The absence of a covalent ﬂavin–protein link in the
L56H variant might be explained by the absence of an acti-
Fig. 6. Phylogenetic analysis of characterized VAO family members. The phylogenetic tree was constructed from a ClustalX multiple sequence alignment
using the neighbor-joining method. (Predicted) covalent ﬂavin linkages are highlighted. Linkages to the N-terminal loop are 8a-N1-histidyl in green and 6-
S-cysteinyl-8a-N1-histidyl in red. Covalent linkages to the C-terminal loop are highlighted in orange. The accession numbers for the sequences used for
phylogenetic analysis are: HDNO, P08159; AknOx, Q0PCD7; AldO, Q9ZBU1; Dictyostelium discoideum ADPS (DdADPS), O96759; Cavia porcellus
ADPS (CpADPS), P97275; ChitO, XP_391174; cholesterol oxidase (CHOX), Q7SID9; Zea mays CKX 1 (ZmCKX1), Q9T0N8; A. thaliana CKX 7
(AtCKX7), Q9FUJ1; Hordeum vulgare CKX 2 (HvCKX2), Q8H6F6; Saccharomyces cerevisiae arabinonolactone oxidase (ScALO), P54783, Candida
albicans ALO (CaALO), O93852; Dbv29, Q7WZ62; D-gluconolactone oxidase (GLO), Q671X8; D-lactate dehydrogenase (DLDH), P06149; DWARF1/
DIMINUTO (DWF1), Q39085; Seladin-1 (24-dehydrocholesterol reductase, SEL1), Q15392; EUGO, Q9RDU1; Pseudomonas sp. HR199 eugenol
hydroxylase ﬂavoprotein subunit (EugR1), AAM21269; Pseudomonas sp. OPS1 eugenol hydroxylase ﬂavoprotein subunit (EugR2), Q0SBK1;
glucooligosaccharide oxidase (GOOX), Q6PW77; glycolate oxidase subunit D (GLCD), P0AEP9; gulonolactone dehydrogenase (GUDH), O06804;
hexose oxidase (HOX), P93762; isoamyl alcohol oxidase (IAAO), Q9HGH9; lactose oxidase (LAO), CAI94231-2; AtGALDH, Q8GY16; Brassica oleracea
GALDH (BoGALDH), O47881; Ipomoea batatas GALDH (IbGALDH), Q9ZWJ1; Nicotiana tabacum GALDH (NtGALDH), Q9SLW6; Rattus
norvegicus gulonolactone oxidase (RnGUO), P10867; Mus musculus GUO (MmGUO), NP_848862; Scyliorhinus torazame GUO (StGUO), Q90YK3;
mitomycin radical oxidase (MMCO), P43485; PCMH ﬂavoprotein subunit, P09788; polykethide synthase (ZEB1), Q2VLJ1; Eschscholzia californica BBE
(EcBBE1), P30986; Papaver somniferum BBE (PsBBE1), P93479; sorbitol oxidase (SorbO), P97011; sunﬂower carbohydrate oxidase (HaCHO), Q8SA59;
tetrahydrocannabinolic acid synthase (THCAS), Q8GTB6; tobacco glucose oxidase (NEC5), Q84N20; TbALO, Q57ZU1; TcGAL, Q4DPZ5; E. coli
MurB (EcMurB), P08373; Staphylococcus aureus MurB (SaMurB), P61431; Streptococcus pneumoniae MurB (SpMurB), P65466; Thermus cadophilus
MurB (TcMurB), Q5SJC8; VAO, P56216; xylitol oxidase (XylO), Q9KX73. The bar indicates 10% divergence.
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for nucleophilic attack. The presence of such an activating
residue is not easily predicted due to the lack of structural
information for the aldonolactone oxidoreductase
subfamily.
The mechanism of L-ascorbate production by
AtGALDH involves two half-reactions. In the reductive
half-reaction, the oxidized ﬂavin cofactor is reduced to
the hydroquinone state by the L-galactono-1,4-lactone sub-strate. The two-electron reduced enzyme is then re-oxidized
in the oxidative half-reaction by cytochrome c. This oxida-
tive half-reaction involves two one-electron steps and the
transient formation of the red anionic ﬂavin semiquinone
[58]. The catalytic mechanism of AtGALDH was studied
with the stopped-ﬂow technique. The reduction of the ﬂa-
vin by L-galactono-1,4-lactone appears to be the rate limit-
ing step in the catalytic cycle (kred = 750 s
1). The re-
oxidation by cytochrome c in the oxidative half-reaction
300 N.G.H. Leferink et al. / Archives of Biochemistry and Biophysics 474 (2008) 292–301occurs relatively fast, with a bimolecular rate constant of
3.6  106 M1 s1, four orders of magnitude faster than
the re-oxidation by molecular oxygen (kox = 4.4 
102 M1 s1).
Trypanosome parasites also contain an aldonolactone
oxidoreductase that harbors a non-covalently bound ﬂavin
cofactor and uses cytochrome c as electron acceptor. The
arabinonolactone oxidase from Trypanosoma brucei
(TbALO) has a preference for substrates in which the C2
and C3 hydroxyl groups are arranged in the trans-conﬁgu-
ration, besides L-galactono-1,4-lactone (Km = 154 lM,
kcat = 21 s
1) it can also oxidize D-arabinono-1,4-lactone
(Km = 55 lM, kcat = 27 s
1) [63]. Galactonolactone oxi-
dase from Trypanosoma cruzi (TcGAL) also utilizes both
L-galactono-1,4-lactone (Km = 161 lM, kcat = 673 s
1)
and D-arabinono-1,4-lactone (Km = 285 lM, kcat =
649 s1) [64]. Considering that L-galactono-1,4-lactone is
the presumed physiological substrate [63,64] and that cyto-
chrome c is employed as electron acceptor, TbALO and
TcGAL should be re-named as galactonolactone
dehydrogenases.
Both TcGAL and TbALO are proposed to possess a
non-covalently bound FMN as cofactor [64]. This would
be the ﬁrst members (together with Dbv29 [43]) of the
VAO-family that contain FMN rather than FAD as the
prosthetic group. However, comparing the sequences of
TcGAL and TbALO with other VAO family members
reveals that the residues that normally interact with the
pyrophosphate and adenine moiety of the FAD cofactor
[1] are conserved in the trypanosomal enzymes. Therefore,
more research is needed to conﬁrm that indeed FMN is
bound to these enzymes rather than FAD. Both TbALO
and TcGAL lack the His residue in the FAD-binding
domain involved in covalent binding of the cofactor, but
contain a Lys residue instead [63,64]. Replacement of
Lys55 of TcGAL by His or Leu yields mutants that are iso-
lated as apoproteins [64]. It is not clear whether the isolated
apoproteins can be reconstituted to the holo form, as is the
case for the AtGALDH Leu56 mutants. Interestingly, a
lysine residue in the C-terminal HWXK motif, conserved
in all aldonolactone oxidoreductases and some related oxi-
dases, is thought to be involved in catalysis of TcGAL.
Replacement of this Lys by Gly (K450G) renders the pro-
tein completely inactive, though ﬂavin is still bound [64].
Although there are no structural rules that enable pre-
diction of whether or how a ﬂavoenzyme reacts with oxy-
gen [29], it is evident that structural data of the
aldonolactone oxidoreductase subfamily would be beneﬁ-
cial in future research towards the elucidation of the molec-
ular determinants of (covalent) ﬂavin binding and oxygen
reactivity.
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